Business Description
Sigma Healthcare Ltd
ISIN : AU000000SIG5
Compare
Compare
Traded in other countries / regions
SIG.AustraliaSIGGF.USAS5YA.Germany IPO Date
2017-05-04Description
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.7 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | 3.19 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 7.28 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.3 | |||||
| 3-Year EBITDA Growth Rate | -17 | |||||
| 3-Year EPS without NRI Growth Rate | -52.8 | |||||
| 3-Year Book Growth Rate | 3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 126.67 | |||||
| Future 3-5Y Total Revenue Growth Rate | 37.85 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.96 | |||||
| 9-Day RSI | 43.52 | |||||
| 14-Day RSI | 51.07 | |||||
| 6-1 Month Momentum % | 100.79 | |||||
| 12-1 Month Momentum % | 155 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.33 | |||||
| Days Inventory | 31.81 | |||||
| Days Sales Outstanding | 42.16 | |||||
| Days Payable | 49.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.38 | |||||
| Forward Dividend Yield % | 0.38 | |||||
| 5-Year Yield-on-Cost % | 0.37 | |||||
| 3-Year Average Share Buyback Ratio | -14.3 | |||||
| Shareholder Yield % | -6.69 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 7.97 | |||||
| Operating Margin % | -0.58 | |||||
| Net Margin % | -0.09 | |||||
| FCF Margin % | -1.96 | |||||
| ROE % | -0.41 | |||||
| ROA % | -0.22 | |||||
| ROIC % | 2.23 | |||||
| ROC (Joel Greenblatt) % | 3.08 | |||||
| ROCE % | 1.77 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 69.47 | |||||
| Shiller PE Ratio | 78.82 | |||||
| Price-to-Owner-Earnings | 1310 | |||||
| PS Ratio | 0.94 | |||||
| PB Ratio | 4.77 | |||||
| Price-to-Tangible-Book | 5.5 | |||||
| EV-to-EBIT | 263.2 | |||||
| EV-to-Forward-EBIT | 17.66 | |||||
| EV-to-EBITDA | 97.76 | |||||
| EV-to-Forward-EBITDA | 11.44 | |||||
| EV-to-Revenue | 1.19 | |||||
| EV-to-Forward-Revenue | 0.25 | |||||
| EV-to-FCF | -60.21 | |||||
| Price-to-Projected-FCF | 3.38 | |||||
| Price-to-Median-PS-Value | 4.13 | |||||
| Price-to-Graham-Number | 12.57 | |||||
| Price-to-Net-Current-Asset-Value | 10.56 | |||||
| Earnings Yield (Greenblatt) % | 0.38 | |||||
| FCF Yield % | -1.61 | |||||
| Forward Rate of Return (Yacktman) % | -1.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sigma Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 3,534.322 | ||
| EPS (TTM) (A$) | -0.004 | ||
| Beta | 1.04 | ||
| Volatility % | 65.94 | ||
| 14-Day RSI | 51.07 | ||
| 14-Day ATR (A$) | 0.110075 | ||
| 20-Day SMA (A$) | 2.7715 | ||
| 12-1 Month Momentum % | 155 | ||
| 52-Week Range (A$) | 0.91 - 3.01 | ||
| Shares Outstanding (Mil) | 1,631.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sigma Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sigma Healthcare Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sigma Healthcare Ltd Frequently Asked Questions
What is Sigma Healthcare Ltd(ASX:SIG)'s stock price today?
The current price of ASX:SIG is A$2.64. The 52 week high of ASX:SIG is A$3.01 and 52 week low is A$0.91.
When is next earnings date of Sigma Healthcare Ltd(ASX:SIG)?
The next earnings date of Sigma Healthcare Ltd(ASX:SIG) is 2025-03-21 Est..
Does Sigma Healthcare Ltd(ASX:SIG) pay dividends? If so, how much?
The Dividend Yield %  of Sigma Healthcare Ltd(ASX:SIG) is 0.38% (As of Today), Highest Dividend Payout Ratio of Sigma Healthcare Ltd(ASX:SIG) was 2.5. The lowest was 0.41. And the median was 1.08. The  Forward Dividend Yield % of Sigma Healthcare Ltd(ASX:SIG) is 0.38%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers